Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitrilase 1 (NIT1) is an enzyme belonging to the nitrilase protein family, best characterized as a deaminated glutathione amidase or metabolite repair enzyme. NIT1 hydrolyzes deaminated glutathione (dGSH), a potentially harmful metabolite produced as a side product of transaminase activity, thereby preventing its accumulation and contributing to cellular detoxification and maintenance of glutathione homeostasis. NIT1 is highly conserved across eukaryotes, localizes to both mitochondria and cytosol, and is implicated in tumor suppression through interactions with proteins such as Fhit and the TGFβ–Smad2/3 signaling pathway. Reduced expression of NIT1 is associated with more aggressive tumor properties in colorectal cancer; however, its role in cancer can be context-dependent, influencing both tumor growth and chemosensitivity in different tissues. No drugs are currently known to target NIT1 directly, and no significant toxicities are linked to its modulation, though its deficiency leads to unique metabolic perturbations.
Hydrolysis of deaminated glutathione (dGSH), a damaging side-product of transaminase activity, to prevent accumulation and cellular toxicity. Potential interaction with tumor suppressor pathways (via physical interaction with Fhit protein and recruitment of Smad2/3 to TGFβ receptors).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrilase 1 (NIT1).